🔎 Trials Near Me

Utama › Kanser Metastatik › Florida › Orlando

Kajian klinikal Kanser Metastatik di Orlando, FL

29 kajian untuk Kanser Metastatik sedang mencari peserta di lokasi dalam dan sekitar Orlando (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Mengambil pesertaFasa 1/2
  • Advent Health, Orlando
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • AdventHealth Cancer Institute, Orlando
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Mengambil pesertaFasa 2/3
  • AdventHealth Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06943755

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Mengambil pesertaFasa 1
  • Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07277413

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Florida Cancer Specialists, Orlando
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • dan 4 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07222566

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Mengambil pesertaFasa 3
  • AdventHealth Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Mengambil pesertaFasa 3
  • AdventHealth Altamonte Springs, Altamonte Springs · 9 mi jauh
  • Clermont Oncology Center, Clermont · 24 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Mengambil pesertaFasa 3
  • AdventHealth Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07213804

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Mengambil pesertaFasa 1/2
  • Orlando Health Ambulatory Care Center, Orlando
  • Orlando Health Cancer Institute, Orlando
  • Orlando Health Orlando Regional Medical Center, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Sep 2026 · NCT07227415

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Clinical Study Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07038343

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Mengambil pesertaFasa 1
  • Sarah Cannon Research Institute - Florida Cancer Specialists, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT04913285

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Mengambil pesertaFasa 3
  • Advent Health - Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Mengambil pesertaFasa 1/2
  • Avenzo Therapeutics Recruiting Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07193511

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Adventhealth, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06803680

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 2
  • Orlando Health, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Mengambil pesertaFasa 1
  • Advent Health, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Mengambil pesertaFasa 3
  • Research Site, Orlando
Umur 18 ke atas · Wanita · Dikemas kini 29 Jul 2026 · NCT07044336

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • Orlando Health UF Health Cancer Center, Orlando
Umur 12 ke atas · Semua jantina · Dikemas kini 14 Jul 2026 · NCT05533697

A Study of LY4175408 in Participants With Advanced Cancer

Mengambil pesertaFasa 1
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jun 2026 · NCT07046923

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

Mengambil pesertaFasa 3
  • Orlando Health Cancer Institute, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT05208047

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Mengambil pesertaFasa 1
  • Research Site, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT06835569

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Mengambil pesertaFasa 3
  • AdventHealth Medical Group Oncology & Hematology at Orlando, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06064877

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Mengambil pesertaFasa 1/2
  • Florida Cancer Specialists, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Apr 2026 · NCT05735080

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • AdventHealth Cancer Institute, Celebration · 17 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mac 2026 · NCT05948865

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Mengambil pesertaFasa 1/2
  • Florida Cancer Specialists-Lake Nona, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Feb 2026 · NCT07030257

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Mengambil pesertaFasa 1
  • Florida Cancer Specialists, Orlando
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Dis 2025 · NCT06108050

Kajian Kanser Metastatik di bandar lain

Kajian lain di Orlando

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.